ArticleNature2022
Selective inhibition of miRNA processing by a herpesvirus-encoded miRNA.
Abstract read
In one paragraph
Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
12.6field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 61 citations in OpenAlex.
- Host-directed clearance of nuclear tegument U14 terminates NF-κB signaling and supports HHV-6A replication.PLoS pathogens · 2026Article
- The HCMV-encoded miR-UL36-3p promotes angiogenesis of endothelial cells by downregulating FOXO3.Animal models and experimental medicine · 2026Article
- Immunoglobulin G complexes from post-infectious ME/CFS, including post-COVID ME/CFS disrupt cellular energetics and alter inflammatory marker secretion.Brain, behavior, & immunity - health · 2026Article
- Cellular miRNAs and viruses: trends in miRNA sequestering and target de-repression.Journal of virology · 2025Review
- Review
- HBV sequence integrated to enhancer acting as oncogenic driver epigenetically promotes hepatocellular carcinoma development.Journal of experimental & clinical cancer research : CR · 2025Article
- Impact of 4-Environment & health (Washington, D.C.) · 2025Article
- Changes and application prospects of biomolecular materials in small extracellular vesicles (sEVs) after flavivirus infection.European journal of medical research · 2025Review
- Overview of host-directed antiviral targets for future research and drug development.Acta pharmaceutica Sinica. B · 2025Review
- MicroRNA Gets a Mighty Award.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Review
- Mitochondrial bioenergetics dysfunction in T2DM: linking oxidative stress to insulin resistance.Frontiers in endocrinology · 2025Review
- Identification of stimuli that enhance human herpesvirus 6A (HHV-6A) replication and reconstitution.Journal of virology · 2024Article
- Research progress on miRNAs function in the interaction between human infectious viruses and hosts: A review.Biomolecules & biomedicine · 2024Review
- Small RNA sequencing analysis reveals regulation of microRNA expression in Madin-Darby canine kidney epithelial cells infected with Canid alphaherpesvirus 1.Virus genes · 2024Article
- Conditional RNA interference in mammalian cells via RNA transactivation.Nature communications · 2024Article
- Article
- Immune escape of avian oncogenic Marek's disease herpesvirus and antagonistic host immune responses.NPJ vaccines · 2024Review
- Anti-miRNA103/107 encapsulated in transferrin-conjugated lipid nanoparticles crosses blood-brain barrier and reduces brain ischemic damage.Molecular therapy. Nucleic acids · 2024Article
- Article
- miRNAs: Targets to Investigate Herpesvirus Infection Associated with Neurological Disorders.International journal of molecular sciences · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 3 institutions in 1 country.
Thomas Hennig *Institute for Virology and Immunobiology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
Archana B Prusty *Department of Biochemistry, Theodor Boveri Institute, Biocenter of the University of Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0003-4749-3175
Benedikt B Kaufer *Institute of Virology, Department of Veterinary Medicine at the Freie Universität Berlin, Berlin, Germany.
Adam W WhisnantInstitute for Virology and Immunobiology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0003-2039-2809
Manivel LodhaInstitute for Virology and Immunobiology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0002-0258-1895
Antje EndersInstitute for Virology and Immunobiology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0001-8657-8580
Julius ThomasInstitute for Virology and Immunobiology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
Francesca KasimirInstitute for Virology and Immunobiology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0003-2778-4610
Arnhild GrotheyInstitute for Virology and Immunobiology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
Teresa KleinDepartment of Biotechnology and Biophysics, Theodor Boveri Institute, Biocenter of the University of Würzburg, Würzburg, Germany.
Stefanie HerbInstitute for Virology and Immunobiology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
Christopher JürgesInstitute for Virology and Immunobiology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0001-5617-6601
Markus SauerDepartment of Biotechnology and Biophysics, Theodor Boveri Institute, Biocenter of the University of Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0002-1692-3219
Utz FischerDepartment of Biochemistry, Theodor Boveri Institute, Biocenter of the University of Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0002-1465-6591
Thomas RudelHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Center for Infection Research (HZI), Würzburg, Germany.ORCID http://orcid.org/0000-0003-4740-6991
Gunter MeisterRegensburg Center for Biochemistry, University of Regensburg, Regensburg, Germany.ORCID http://orcid.org/0000-0002-2098-9923
Florian ErhardInstitute for Virology and Immunobiology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0002-3574-6983
Lars DölkenInstitute for Virology and Immunobiology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany. lars.doelken@uni-wuerzburg.de.ORCID http://orcid.org/0000-0002-4651-3544
Bhupesh K PrustyInstitute for Virology and Immunobiology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany. bhupesh.prusty@uni-wuerzburg.de.ORCID http://orcid.org/0000-0001-7051-4670
University of Würzburg · DEFreie Universität Berlin · DEUniversity of Regensburg · DE
Funding
European Research Council
Abstract
Herpesviruses have mastered host cell modulation and immune evasion to augment productive infection, life-long latency and reactivation
Indexed as
HerpesviridaeMicroRNAsHumansImmune EvasionRNA InterferenceRNA Processing, Post-TranscriptionalVirus LatencyMicroRNAs
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.